MK

Michael Krel

Partner at Sofinnova Partners

Greater Paris Metropolitan Region

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

2022

  • Board Member

    2022

2021

  • Board Member

    2021

  • Board Member

    2021

2023

  • Board Member

    2023

  • Partner

    2020

    Part of the Sofinnova Industrial biotech team : We leverage biotechnologies to save the world!

  • Principal

    2017 - 2020

  • senior associate

    2013 - 2017

    l focus on early stages investments in the industrial biotechnology and renewable chemistry sectors in Europe and beyond.

2020

  • Board Member

    2020

2019

  • Board member

    2019

2016

  • Board observer

    2016

2015

  • Member of the Board

    2017

  • CEO

    2015 - 2017

    EnobraQ is a an early stage startup focused on enabling the use of CO2 as an industrial fermentation feedstock; while still with Sofinnova Partners, I am (part time) CEO of EnobraQ, a Sofinnova's portfolio company

2010 - 2013

  • VP Business Development

    2010 - 2013

    1) responsible for the business development of the company, from market study up to deal closing 2) coordination of the partenrship and collaboration with other companies 3) participation to the financial and administrative management of the company